High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, May 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 2 policy sources

twitter: 8 X users
facebook: 3 Facebook pages

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 254 Mendeley

Summary News Blogs Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Combination Therapy for the Treatment of Adults with Any Stage Breast Cancer: Clinical Effectiveness and Guidelines

Cited by Canadian Agency for Drugs and Technologies in Health on 05 Feb 2019

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Olaratumab in combination with doxorubicin for treating advanced soft tissue sarcoma: Committee papers

Cited by National Institute for Health and Care Excellence on 08 Jun 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.